Ascendis Pharma A/S (ASND) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist

123.975
+1.175+0.96%

Trading Oct 31 14:02 ET

7.41BMarket Cap-13248P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

While Shareholders of Ascendis Pharma (NASDAQ:ASND) Are in the Black Over 1 Year, Those Who Bought a Week Ago Aren't so Fortunate
Simply Wall StOct 31 06:24 ET
BioMarin's Pipeline Faces Skepticism As Analyst Questions Future Growth
Analyst UpgradesOct 30 14:42 ET
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading
MT NewswiresOct 28 11:16 ET
BofA Securities Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $191
Moomoo NewsOct 24 06:31 ET · Ratings
J.P. Morgan Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Cuts Target Price to $174
Moomoo NewsOct 23 07:35 ET · Ratings
Express News | Ascendis Pharma A/S : JP Morgan Cuts Target Price to $174 From $180
ReutersOct 23 02:07 ET

Comments

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$

1

$Ascendis Pharma A/S (ASND.US)$ big rebound from drop after financials , from 111 to 150. that's a good profit for those who payed attention. $NVIDIA (NVDA.US)$ $Apple (AAPL.US)$

1

$Ascendis Pharma A/S (ASND.US)$ reporting wasn't so terrible that it deserves a15% drop. could see this rebounding above the price before the drop

1

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Nice curl! On watch for recovery. May swing.

$Ascendis Pharma A/S (ASND.US)$

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data